DRW Securities’s Neurocrine Biosciences NBIX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-2,700	Closed	-$304K	–	340
2023 Q3	$304K	Buy	+2,700	New	+$304K	0.01%	197
2014 Q1	–	Sell	-19,000	Closed	-$177K	–	169
2013 Q4	$177K	Buy	+19,000	New	+$177K	0.01%	171